Biotechnology New York City

Lev is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Lev's lead product candidate, Cinryze (C1 inhibitor), is being developed as a replacement therapy both for the ...

GenomeWeb LLC is an independent, privately-held online and print publisher based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in ...

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to ...

GenomeWeb LLC is an independent, privately-held online and print publisher based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in ...

Advanced Viral Research Corp. (Advanced Viral) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. The Company's products ...

AusAm is developing a new class of anti-viral compounds known as attachment inhibitors. Our attachment inhibitors are polysaccharide-based compounds that prevent a virus from attaching to and infecting its target cell. AusAm's lead anti-viral compound ...

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to ...

SIGA Technologies, Inc. (SIGA) is a biotechnology company that discovers, develops and commercializes anti-infectives for serious infectious diseases. The major focus of the Company's developmental and commercialization activities is on products for use ...

Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company focused primarily on the development of drugs to treat neuroendocrine cancer (including advanced carcinoid cancer), acute leukemia and gastrointestinal disorders and diseases. The ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The philosophy behind Bio Balance is that accurate descriptions of drug-receptor interactions will lead to the development of better pharmaceuticals ...

About Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. Eyetech's initial focus is on diseases affecting ...

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to ...

Cadus Corporation is engaged in the development and application of yeast-based and other drug discovery technologies. The Company has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all applications, licenses and drug ...

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to ...

Bioenvision's primary focus is the acquisition, development, distribution and marketing of compounds and technologies for the treatment of cancer. Bioenvision has a broad pipeline of products for the treatment of cancer, including: Evoltra(TM), Modrenal(R ...

Bioenvision's primary focus is the acquisition, development, distribution and marketing of compounds and technologies for the treatment of cancer. Bioenvision has a broad pipeline of products for the treatment of cancer, including: Evoltra(TM), Modrenal(R ...

SIGA Technologies, Inc. (SIGA) is a biotechnology company that discovers, develops and commercializes anti-infectives for serious infectious diseases. The major focus of the Company's developmental and commercialization activities is on products for use ...

Bioenvision's primary focus is the acquisition, development, distribution and marketing of compounds and technologies for the treatment of cancer. Bioenvision has a broad pipeline of products for the treatment of cancer, including: Evoltra(TM), Modrenal(R ...

Cadus Corporation is engaged in the development and application of yeast-based and other drug discovery technologies. The Company has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all applications, licenses and drug ...

Cadus Corporation is engaged in the development and application of yeast-based and other drug discovery technologies. The Company has a wholly owned subsidiary, Cadus Technologies, Inc. (the Subsidiary), which holds all applications, licenses and drug ...

Neuro-Hitech, Inc. (Neuro-Hitech) is an early stage pharmaceutical company focused on developing drugs for the treatment of degenerative neurological diseases. The Company’s principal product candidate, Huperzine A, completed a Phase II clinical trial ...

GenomeWeb LLC is an independent, privately-held online and print publisher based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in ...

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The philosophy behind Bio Balance is that accurate descriptions of drug-receptor interactions will lead to the development of better pharmaceuticals ...

Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company focused primarily on the development of drugs to treat neuroendocrine cancer (including advanced carcinoid cancer), acute leukemia and gastrointestinal disorders and diseases. The ...